Results 191 to 200 of about 72,933 (233)

Long non-coding RNAs in response to Ebola virus vaccine-induced immunity. [PDF]

Front Immunol
Mamede I, Luschër-Dias T, Moscardini IF, Gonzales-Dias P, Marinho B, Marcon F, Dominguez Crespo Hirata T, Eichberg M, Medaglini D, Harandi AM, Siegrist CA, Ottenhoff THM, Santoro F, Gonçalves A, Ferreira DM, Polidoro R, Franco GR, Amaral PP, Nakaya H, Addo MM, VSV-EBOPLUS Consortium .   +20 more
europepmc   +1 more source

Development and Application of a Pseudovirus-Based Assay for Modelling SARS-CoV-2 Spike Protein Mediated Drug Screening. [PDF]

Int J Mol Sci
Khasanov SA, Esaulkova IL, Volobueva AS, Slita AV, Kriger DV, Tentler D, Yarovaya OI, Sokolova AS, Gorshkov AN, Dolgova AS, Lavrentieva IN, Dedkov VG, Salakhutdinov NF, Zarubaev VV.   +13 more
europepmc   +1 more source

Fostamatinib (R788), a spleen tyrosine kinase inhibitor, sensitizes pancreatic cancer cells to oncolytic vesicular stomatitis virus. [PDF]

Mol Ther Oncol
Catacalos-Goad C, Goad DW, Holbrook MC, Krueger Q, Wilson IM, Hajjar MA, Grdzelishvili VZ.   +6 more
europepmc   +1 more source

T cells assemble lentivirus to solve local delivery of stable gene therapy. [PDF]

Sci Rep
Detuncq J.
europepmc   +1 more source

Development of immortalized Callithrix jacchus kidney cell lines supporting infection with a panel of viruses. [PDF]

PLoS One
Gärtner S, Stomberg P, Pöhlmann S, Winkler M.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Replicating-Competent VSV-Vectored Pseudotyped Viruses

2023
Vesicular stomatitis virus (VSV) is prototype virus in the family of Rhabdoviridae. Reverse genetic platform has enabled the genetic manipulation of VSV as a powerful live viral vector. Replicating-competent VSV is constructed by replacing the original VSV glycoprotein gene with heterologous envelope genes. The resulting recombinant viruses are able to
Fei, Yuan, Aihua, Zheng
openaire   +2 more sources

Inducible Vesicular Stomatitis Virus (VSV) L Cell Line for Packaging of Recombinant VSV

Virus Genes, 2005
Recently, recombinant vesicular stomatitis viruses (VSV) have been developed as high-level expression vectors which serve as effective vaccine vectors in animals. An ideal approach for VSV vector production would be the development of stable packaging cell lines that can produce vector particles without transfection step.
Seong-Karp, Hong, Yong-Tae, Jung, Seung-Won, Park, Soon-Young, Paik   +3 more
openaire   +2 more sources

Interaction of VSV leader RNA and nucleocapsid protein may control VSV genome replication

Cell, 1981
The discovery of plus- and minus-strand leader RNAs (short RNAs that are the complement of the exact 3' ends of the viral minus-strand genome and plus-strand antigenome) in VSV-infected cells has led to a model of genome replication in which the viral nucleocapsid protein acts as a modulator of genome transcription and replication.
B M, Blumberg, M, Leppert, D, Kolakofsky
openaire   +2 more sources

Inhibition of VSV binding and infectivity by phosphatidylserine: Is phosphatidylserine a VSV-binding site?

Cell, 1983
Recently we described a saturable, high-affinity binding site for vesicular stomatitis virus (VSV) on the surface of Vero cells that appears to mediate viral infectivity. To isolate this binding site, we have extracted Vero cells with the detergent, octyl-beta-D-glucopyranoside.
R, Schlegel, T S, Tralka, M C, Willingham, I, Pastan   +3 more
openaire   +2 more sources

Limitation of VSV infection by the host's response to VSV-associated cellular antigens.

The Journal of Immunology, 1982
Abstract It has been reported that during the maturation of enveloped viruses, host proteins such as H-2 antigens of the mouse associate with the budding viruses. This finding led us to investigate the possible biologic significance of this association.
T T, Hecht, W E, Paul
openaire   +2 more sources